在监狱和社区中启动美沙酮治疗：患者差异以及美沙酮治疗减少逮捕的影响。
Initiating methadone in jail and in the community: Patient differences and implications of methadone treatment for reducing arrests.
机构信息
Friends Research Institute, Baltimore, MD, USA.
Friends Research Institute, Baltimore, MD, USA.
出版信息
J Subst Abuse Treat. 2019 Feb;97:7-13. doi: 10.1016/j.jsat.2018.11.006. Epub 2018 Nov 19.
The extent to which patient characteristics differ between individuals entering methadone treatment through community programs and jail-based programs is not known. Such differences could impact the likelihood of relapse and recidivism in these two populations and inform efforts at targeting interventions. We compared treatment-entry characteristics of participants enrolling in methadone treatment in two studies conducted in Baltimore, one conducted in community programs (N = 295) and the other in a jail-based program (N = 225). Controlling for age, race, and gender, individuals starting methadone treatment in jail compared to the community, had more severe drug use and criminal justice profiles. These different characteristics suggest that patients initiating methadone in a jail-based program could have greater likelihood of future arrest compared to patients entering community-based treatment. CLINICAL TRIALS REGISTRATION: Clinicaltrials.gov NCT 02334215 and NCT 01442493.
尚不清楚通过社区项目和监狱项目进入美沙酮治疗的个体之间患者特征的差异程度。这些差异可能会影响这两个人群中复发和再犯罪的可能性，并为有针对性的干预措施提供信息。我们比较了在巴尔的摩进行的两项研究中参加美沙酮治疗的参与者的治疗开始特征，一项在社区项目中进行（N=295），另一项在监狱项目中进行（N=225）。控制年龄、种族和性别后，与社区相比，在监狱开始美沙酮治疗的个体具有更严重的药物使用和刑事司法特征。这些不同的特征表明，与进入社区为基础的治疗的患者相比，在监狱为基础的项目中开始美沙酮治疗的患者未来被捕的可能性更大。临床试验注册：Clinicaltrials.gov NCT 02334215 和 NCT 01442493。
Zotero 插件